{"id":24101,"date":"2016-01-27T11:25:41","date_gmt":"2016-01-27T10:25:41","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=24101"},"modified":"2016-01-28T11:26:30","modified_gmt":"2016-01-28T10:26:30","slug":"novartis-ceo-jimenez-ha-guadagnato-quasi-12-milioni-nel-2015","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/novartis-ceo-jimenez-ha-guadagnato-quasi-12-milioni-nel-2015\/","title":{"rendered":"Novartis: CEO Jimenez earned nearly 12 million in 2015"},"content":{"rendered":"
\n

THE\"\"The chairman of the management of Novartis, Joseph Jimenez, received total remuneration of 11.6 million francs last year, against 12.6 million the previous year. The basic salary is 2.1 million.<\/p>\n

David Epstein, director of the pharmaceutical division, also saw his salary fall, to about 9 million dollars (9.46 million francs at current exchange rates), compared to 9.3 million a year earlier, Novartis indicated, publishing today its 2015 annual activity report. Epstein's data is in dollars, while those of his colleagues do not.<\/p>\n

The overall Directorate-General reached a total amount of almost 52 million francs, compared to 69.2 million in 2014.<\/p>\n

As for the board of directors, Novartis chairman J\u00f6rg Reinhardt received 3.8 million francs last year, against 4 million the previous year. Overall, the supervisory body was awarded 7.8 million (8.8 million in 2014).<\/p>\n<\/div>\n

sda-ats<\/p>\n

27 JANUARY 2016 \u2013 SWI swissinfo<\/span><\/a><\/p>\n

Related news: Bloomberg: Joseph Jimenez Jr. Fiscal Year 2014<\/a><\/span><\/p>\n

Novartis: 2015 profit drops to 6.47 billion<\/span><\/a><\/p>\n

NB<\/strong>.: at today's exchange rate 1\u20ac is equivalent to 1.10 Fr.S, i.e. 1 euro is exchanged at 0.91 Fr.S<\/p>","protected":false},"excerpt":{"rendered":"

Il presidente della direzione di Novartis, Joseph Jimenez, ha percepito l’anno scorso una remunerazione totale di 11,6 milioni di franchi, contro i 12,6 milioni precedenti, Lo stipendio base \u00e8 di 2,1 milioni. Anche David Epstein, direttore della divisione farmaceutica, ha visto il suo salario ridursi, a circa 9 milioni di dollari (9,46 milioni di franchi …<\/p>","protected":false},"author":4,"featured_media":1693,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[51],"class_list":["post-24101","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-compenso-top-manager"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/24101","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=24101"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/24101\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/1693"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=24101"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=24101"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=24101"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}